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Dimethyl sulfoxide (DMSO) is frequently utilized as a solvent in toxicological and
pharmaceutical investigations. It is therefore important to establish the cellular and
molecular targets of DMSO in order to differentiate its intrinsic effects from those
elicited by a compound of interest. We performed a genome-wide functional screen in
Saccharomyces cerevisiae to identify deletion mutants exhibiting sensitivity to 1% DMSO,
a concentration standard to yeast chemical profiling studies. We report that mutants
defective in Golgi/ER transport are sensitive to DMSO, including those lacking components
of the conserved oligomeric Golgi (COG) complex. Moreover, strains deleted for members
of the SWR1 histone exchange complex are hypersensitive to DMSO, with additional
chromatin remodeling mutants displaying a range of growth defects. We also identify DNA
repair genes important for DMSO tolerance. Finally, we demonstrate that overexpression
of histone H2A.Z, which replaces chromatin-associated histone H2A in a SWR1-catalyzed
reaction, confers resistance to DMSO. Many yeast genes described in this study have
homologs in more complex organisms, and the data provided is applicable to future
investigations into the cellular and molecular mechanisms of DMSO toxicity.
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INTRODUCTION
The dipolarity and low toxicity of dimethyl sulfoxide (DMSO)
make it an unrivaled solvent in the field of toxicology. DMSO
elicits numerous cellular effects, demonstrating the capac-
ity to serve as a cryoprotectant, hydroxyl radical scavenger,
and inducer of cellular differentiation and fusion (reviewed
by Yu and Quinn, 1994). The pharmacological properties of
DMSO have been documented in the treatment of brain
edema, amyloidosis, rheumatoid arthritis, and schizophrenia,
with infrequently reported systemic toxicities (Santos et al.,
2003). The ubiquity of DMSO as a toxicant and drug sol-
vent demands further identification of the cellular and molec-
ular processes it may perturb, primarily to discern whether
its effects influence those mediated by a compound of
interest.
The unique genetic tools available in the model eukaryote
Saccharomyces cerevisiae facilitate investigations into the cellular
and molecular mechanisms of chemical resistance. The collec-
tion of barcoded yeast deletion mutants (Giaever et al., 2002)
can be exploited to conduct functional genomic analyses (other-
wise known as functional profiling) for a compound of interest.
Pools of mutants are subjected to chemical treatment, and after
DNA extraction, the strain-specific barcodes are amplified and
hybridized to a microarray. Signal intensities correspond to strain
numbers present in the pool after exposure, and indicate how the
given insult alters the growth of individual mutants. With a high
degree of conservation to more complex organisms (Steinmetz
et al., 2002), yeast is an appealing model that can help identify
human chemical susceptibility or resistance genes (Jo et al., 2009a;
Blackman et al., 2012).
In this study, we utilized a genome-wide functional screen
to identify yeast mutants exhibiting sensitivity to the common
solvent DMSO. During preparation of this manuscript, a study
was published implicating transcriptional control machinery and
cell wall integrity as necessary for DMSO tolerance in S. cere-
visiae (Zhang et al., 2013). Similarly, our results demonstrate
that mutants lacking components of the SWR1 histone exchange
complex exhibit hypersensitivity to DMSO. Here we corrobo-
rate and extend Zhang et al. (2013) by identifying additional
SWR1 and conserved oligomeric Golgi (COG) complex mem-
bers as required for DMSO resistance. We also provide extensive
dose-response data for various deletion strains and present sev-
eral novel DMSO-sensitive mutants. Finally, we indicate that
overexpression of histone H2A.Z can confer DMSO resistance.
Many yeast genes identified in this investigation have homologs
that may contribute to DMSO response in more complex
organisms.
MATERIALS AND METHODS
YEAST STRAINS AND CULTURE
Functional profiling and confirmation analyses utilized the
collection of BY4743 non-essential diploid yeast deletion strains
(MATa/MATα his31/his31 leu20/leu20 lys20/LYS2
MET15/met150 ura30/ura30, Invitrogen). All assays were
performed in liquid rich media (1% yeast extract, 2% peptone,
2% dextrose, YPD) at 30◦C with shaking at 200 rpm, except
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overexpression experiments, which used liquid rich media
containing 2% galactose and 2% raffinose (YPGal + Raf). For
overexpression analyses, the HTZ1 and ARP6 HIP FlexGene
expression vectors were transformed into strains of the BY4743
background.
FUNCTIONAL PROFILING OF THE YEAST GENOME AND
OVERENRICHMENT ANALYSES
Growth of the homozygous diploid deletion pools (4607 mutants
in total), DNA extraction, PCR-amplification of strain barcodes,
hybridization of Affymetrix TAG4 arrays, and differential strain
sensitivity analysis (DSSA) were performed as described (Jo et al.,
2009b). For DSSA, twelve 1%DMSO replicates were compared to
12 YPD replicates. Data files are available at the Gene Expression
Omnibus (GEO) database. Significantly overrepresented Gene
Ontology (GO) and MIPS (Munich Information Center for
Protein Sequences) categories within the functional profiling data
were identified with FunSpec (Robinson et al., 2002), using a
p-value cutoff of 0.001 and Bonferroni correction.
GROWTH CURVE AND FLOW CYTOMETRY CONFIRMATION ASSAYS
Growth curve assays were performed as in North et al. (2011),
with DMSO (VWR, #EM-MX1458-6) added to the desired
final concentrations at a minimum two technical replicates
per dose. Confirmation of growth defects by a flow cytome-
try based relative growth assay was performed as in Gaytán
et al. (2013). Briefly, a culture containing GFP-tagged wild-
type and untagged mutant cells was treated with DMSO, and
a ratio of growth was calculated for untagged cells in treated
versus untreated samples, as compared to the GFP strain. All
graphs display the mean and standard error of three inde-
pendent cultures. Three tests—regular t-test, Welch’s test (t-
test modification assuming unequal variances) and Wilcoxon
Rank Sum (Mann–Whitney) test—were simultaneously applied
to assess how possible violations of the assumptions underlying
t-test (homoscedasticity and normality) affect statistical infer-
ence outcomes for the data. Raw p-values for each test statistic
were corrected for multiplicity of comparisons using Benjamini–
Hochberg correction. P-values indicated on graphs are derived
from regular t-tests, with Welch and Wilcoxon Rank Sum test
results (which are more robust but more conservative in terms
of adjusted p-values) usually in agreement with regular t-tests
(Table S1).
RESULTS
FUNCTIONAL PROFILING IN YEAST IDENTIFIES GENES REQUIRED FOR
DMSO TOLERANCE
Following growth of yeast homozygous diploid deletion mutant
pools for 15 generations in 1% DMSO, DSSA identified 40
strains as sensitive to DMSO, as compared to YPD controls
(Table 1; Table S2). To identify the biological attributes required
for DMSO tolerance, enrichment analyses for the 40 sensitive
strains was performed with FunSpec at a corrected p-value of
0.001. The COG complex, as well as its biological functions
(cytoplasm to vacuole targeting pathway and intra-Golgi trans-
port), were overrepresented in both GO and MIPS categories
(Table 2).
MUTANTS DEFECTIVE IN GOLGI/ER TRANSPORT ARE SENSITIVE TO
DMSO
Overrepresentation analyses suggested that subunits of COG,
a protein complex that mediates fusion of transport vesicles
to Golgi compartments, were required for DMSO tolerance.
Therefore, we performed relative growth assays in which the
growth of COG deletion strains was compared to a wild-type
GFP-expressing strain in various DMSO concentrations. Deletion
of genes encoding any of the four non-essential subunits of COG
(COG5, COG6, COG7, and COG8) resulted in dose-dependent
sensitivity to DMSO, with statistically significant growth defects
observed at DMSO concentrations as low as 0.25% (Figure 1A).
Growth curve assays also confirmed sensitivity of the individual
COG deletions under non-competitive conditions (Figure 1B).
To identify additional sensitive Golgi/ER transport strains not
present in the functional profiling data, we tested the DMSO
sensitivity of various mutants displaying synthetic lethality or
sickness with at least one COG gene. Analysis of relative growth
by flow cytometry found that strains lacking vacuolar SNAREs
(vam7 and gos1) were DMSO-sensitive (Figure 1A). Growth
curve experiments were performed as an alternative for strains
demonstrating severe fitness defects in the relative growth assay,
with mutants defective in retrograde Golgi transport (ric1,
vps51, and vps54) as well as those deleted for components
of the Guided Entry of Tailanchored (GET) Golgi/ER trafficking
complex (get1 and get2) exhibiting dose-dependent DMSO
sensitivity (Figure 1B).
CHROMATIN REMODELING MACHINERY IS REQUIRED FOR DMSO
TOLERANCE
The yaf9 strain, which lacks a subunit common to the
SWR1 histone exchange and NuA4 histone H4 acetyltrans-
ferase complexes, was identified by DSSA as DMSO-sensitive
(Table 1) and confirmed by both competitive growth and growth
curve assays to exhibit severe DMSO-dependent growth defects
(Figures 2A,B). This stark phenotype prompted us to exam-
ine all non-essential SWR1 and NuA4 deletions for DMSO
sensitivity, as SWR1 and NuA4 complexes cooperate to alter
chromatin structure in yeast (reviewed by Lu et al., 2009).
Except for swc7, every SWR1 mutant (swr1, swc2, swc3,
swc5, swc6, arp6, and bdf1) was confirmed as sensi-
tive to DMSO, with most displaying similar dose-dependent
growth inhibition (Figures 2A,B). Moreover, htz1, a strain
lacking the histone variant H2A.Z exchanged for histone H2A
in nucleosomes by the SWR1 complex (Mizuguchi et al.,
2004), displayed growth defects in DMSO (Figure 2A). Several,
but not all, non-essential NuA4 deletion mutants (eaf1,
eaf3, and eaf7, but not eaf5 or eaf6) were DMSO-
sensitive, however, levels of DMSO-mediated growth inhibi-
tion did not approach that of the SWR1 mutants (Figure 2A).
We tested additional strains exhibiting both (1) defects in
histone modification and (2) synthetic lethality or sickness
with SWR1 and/or NuA4 genes (Collins et al., 2007; Mitchell
et al., 2008; Costanzo et al., 2010; Hoppins et al., 2011).
Absence of components of the Set1C histone H3 methy-
lase (swd1, swd3, and spp1), the Set3C histone deacety-
lase (set3, sif2, and hos2, but not snt1), the SAGA
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Table 1 | Fitness scores for deletion strains identified as significantly sensitive to 1% DMSO during a 15 generation treatment.
ORF Deleted gene Log2 value Description of deleted gene Confirmed
1% DMSO
YIL162W SUC2 −4.54 Invertase, sucrose hydrolyzing enzyme NS
YHR010W RPL27A −2.45 Component of the large (60S) ribosomal subunit
YDR083W RRP8 −2.41 Nucleolar protein involved in rRNA processing S
YNL051W COG5 −2.38 Component of conserved oligomeric Golgi complex; functions in protein trafficking S
YER156C - −2.31 Putative protein of unknown function
YOR304C-A - −2.26 Protein of unknown function S
YML071C COG8 −2.11 Component of conserved oligomeric Golgi complex; functions in protein trafficking S
YLR371W ROM2 −2.10 GDP/GTP exchange protein (GEP) for Rho1p and Rho2p S
YJL132W - −2.07 Putative protein of unknown function NS
YKR024C DBP7 −1.93 Putative ATP-dependent RNA helicase; involved in ribosomal biogenesis NS
YFR034C PHO4 −1.91 Transcription factor of the myc-family; regulated by phosphate availability NS
YNL107W YAF9 −1.90 Subunit of NuA4 histone H4 acetyltransferase and SWR1 complex S
YLR322W VPS65 −1.83 Dubious ORF; overlaps the verified gene SFH1; deletion causes VPS defects
YFR036W CDC26 −1.65 Subunit of the Anaphase-Promoting Complex/Cyclosome (APC/C) NS
YFR045W - −1.62 Putative mitochondrial transport protein
YKR019C IRS4 −1.61 Involved in regulating phosphatidylinositol 4,5-bisphosphate levels and autophagy
YNL041C COG6 −1.57 Component of conserved oligomeric Golgi complex; functions in protein trafficking S
YLR261C VPS63 −1.54 Dubious ORF; overlaps the verified gene YPT6; deletion causes VPS defects
YBR227C MCX1 −1.50 Mitochondrial matrix protein; putative ATP-binding chaperone
YGL005C COG7 −1.47 Component of conserved oligomeric Golgi complex; functions in protein trafficking S
YJL205C NCE101 −1.41 Protein of unknown function; involved in secretion of proteins
YER032W FIR1 −1.39 Involved in 3’ mRNA processing
YEL039C CYC7 −1.36 Cytochrome c isoform 2
YER110C KAP123 −1.35 Karyopherin, mediates nuclear import of ribosomal proteins and histones H3/H4 S
YGL158W RCK1 −1.35 Protein kinase involved in the response to oxidative stress NS
YBR013C - −1.28 Putative protein of unknown function
YGL031C RPL24A −1.26 Ribosomal protein L30 of the large (60S) ribosomal subunit
YML116W ATR1 −1.24 Multidrug efflux pump of the major facilitator superfamily
YJR140C HIR3 −1.22 Subunit of the HIR nucleosome assembly complex S
YNL198C - −1.19 Dubious ORF unlikely to encode a protein
YGL139W FLC3 −1.14 Putative FAD transporter
YGR089W NNF2 −1.08 Interacts physically and genetically with Rpb8p (a subunit of RNA pols. I/II/III)
YKL040C NFU1 −1.06 Involved in iron metabolism in mitochondria
YAL015C NTG1 −1.05 DNA N-glycosylase and AP lyase involved in base excision repair S
YGR108W CLB1 −1.03 B-type cyclin involved in cell cycle progression
YCR067C SED4 −0.92 Integral endoplasmic reticulum membrane protein
YIR001C SGN1 −0.90 Cytoplasmic RNA-binding protein; may have a role in mRNA translation
YDL211C - −0.88 Putative protein of unknown function; GFP-fusion protein localizes to vacuole
YDR534C FIT1 −0.88 Mannoprotein that is incorporated into the cell wall
YER098W UBP9 −0.87 Ubiquitin-specific protease that cleaves ubiquitin-protein fusions
Fitness is defined as the normalized log2 ratio of strain growth in the presence vs. absence of DMSO. The confirmed column indicates whether the strain was
confirmed as sensitive (S) or not sensitive (NS) by relative growth assays. Sensitivity is defined as a relative growth ratio of <0.9 in DMSO versus a wild-type GFP
expressing strain.
acetyltransferase (gcn5) and histone H2B deubiquitylation
module (sgf11 and ubp8), and the Paf1 transcription initi-
ation complex (cdc73) conferred DMSO sensitivity, although
none displayed DMSO-mediated growth defects as drastic as
SWR1 mutants (Figures 3A–D). DSSA and our relative growth
assay identified HIR3, a gene encoding a subunit of the
histone regulation (HIR) nucleosome assembly complex, as
required for DMSO tolerance, with additional HIR members
(HIR1, HIR2, HPC2) also confirmed as necessary for resistance
(Figure 3E).
ADDITIONAL MUTANTS, INCLUDING THOSE INVOLVED IN DNA
REPAIR, ARE SENSITIVE TO DMSO
The NTG1 gene, which encodes a DNA N-glycosylase and
apurinic/apyrimidinic lyase involved in base excision repair (Eide
et al., 1996), was identified by DSSA as required for DMSO
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Table 2 | MIPS or GO categories associated with genes required for DMSO resistance.
p-value Genes identified ka f b
GO BIOLOGICAL PROCESS CATEGORY
Cytoplasm to vacuole targeting (CVT) pathway [GO:0032258] 2.38E–006 COG7 IRS4 COG8 COG6 COG5 5 37
Intra-Golgi vesicle-mediated transport [GO:0006891] 1.12E–005 COG7 COG8 COG6 COG5 4 24
GO CELLULAR COMPONENT CATEGORY
Golgi transport complex [GO:0017119] 7.94E–008 COG7 COG8 COG6 COG5 4 8
Golgi membrane [GO:0000139] 6.43E–004 SED4 COG7 COG8 COG6 COG5 5 117
MIPS FUNCTIONAL CLASSIFICATION CATEGORY
Intra Golgi transport [20.09.07.05] 4.16E–005 COG7 COG8 COG6 COG5 4 33
Strains exhibiting sensitivity to 1% DMSO, as identified by DSSA, were analyzed with FunSpec for overrepresented biological attributes.
aNumber of genes in category identified as sensitive to DMSO.
bNumber of genes in GO or MIPS category.
FIGURE 1 | Golgi/ER transport mutants are sensitive to DMSO.
Statistical significance between wild-type and mutant strains was
calculated by t-test, where ap < 0.001, bp < 0.01, and cp < 0.05. (A)
Assessment of COG and vacuolar SNARE mutant growth in DMSO. Mutant
strains were grown in competition with a GFP-expressing wild-type strain in
the indicated DMSO concentrations and relative growth ratios (treatment
vs. control) were obtained. The ratio means and standard errors are shown
for three independent cultures. (B) Analysis of COG, GET, and
Golgi-Associated Retrograde Protein (GARP) deletions in DMSO. Growth
curves for three independent cultures were obtained for the indicated
strains and doses of DMSO. The area under the curve (AUC) was calculated
and is shown as a percentage of the untreated strain’s AUC.
resistance (Table 1). Our relative growth assay confirmed ntg1
as sensitive to DMSO, but interestingly, deletion of theNTG1 par-
alog NTG2 did not markedly alter growth in DMSO (Figure 4A).
A strain deleted forMRE11, a component of the meiotic recombi-
nation (MRX) complex involved in repair of DNA double-strand
breaks (and exhibiting synthetic sickness with EAF1 of NuA4),
was also sensitive to DMSO (Figure 4A). Deletions in prefoldin
(pac10 and yke2), a complex involved in the folding of tubu-
lin and actin, were sensitive to DMSO (Figure 4B). Other genes
necessary for DMSO tolerance included ROM2 (a GDP/GTP
exchange factor for the Rho family), EDO1 (of unknown func-
tion), RRP8 (an rRNAmethyltransferase), andKAP123 (a nuclear
importer of histones H3 and H4) (Figure 4C).
OVEREXPRESSION OF H2A.Z CONFERS RESISTANCE TO DMSO
After demonstrating a role for the SWR1 histone exchange
machinery and its accessories in DMSO tolerance (Figure 2),
we examined whether overexpression of Htz1p (histone H2A.Z
exchanged for H2A by SWR1) or Arp6p (the nucleosome
binding component of SWR1) could rescue the DMSO sen-
sitivity of various strains. Increased levels of Htz1p reversed
the DMSO sensitivity of BY4743 wild-type and htz1,
but interestingly, caused growth defects with 1% DMSO
in the yaf9 strain (Figure 5). It did not affect sensitiv-
ity of the ntg1 DNA repair mutant (data not shown).
Although Arp6p overexpression provided DMSO resistance
to the ntg1 mutant (Figure 5), it did not alter the growth
of wild-type, htz1, or yaf9 strains in DMSO (data not
shown).
DISCUSSION
DMSO is a polar and aprotic solvent commonly utilized to solu-
bilize chemicals during toxicological or pharmaceutical inquiries
(Santos et al., 2003). Compared to other solvents within its
class such as sulfolane, N,N-dimethylformamide, N-methyl-
pyrrolidin-2-one, or N,N-dimethyl acetamide, DMSO exhibits
relatively limited acute toxicity (Tilstam, 2012), thus affording
it preferred status within these fields. Despite its universality,
DMSO’s molecular mechanism(s) of action remain ambiguous,
thus requiring investigations into the cellular processes and path-
ways it may perturb. Here we conducted a genome-wide func-
tional screen in the model eukaryote S. cerevisiae to identify
the non-essential yeast deletion mutants experiencing growth
defects in 1% DMSO, a concentration typical to yeast toxi-
cant or drug profiling studies. We demonstrate that components
of the COG Golgi/ER transport and SWR1 histone exchange
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FIGURE 2 | SWR1 histone exchange and NuA4 histone H4
acetyltransferase mutants are sensitive to DMSO. Statistical
significance between wild-type and mutant strains was determined by
t-test, where ap < 0.001, bp < 0.01, and cp < 0.05. (A) Assessment
of DMSO treatment on strains lacking components of SWR1 or
NuA4. Relative growth ratios were obtained for three independent
cultures and analyzed as described in Materials and Methods. (B)
Evaluation of the bdf1 and yaf9 SWR1 mutants in DMSO.
Growth curves were acquired from three independent cultures at the
indicated doses.
FIGURE 3 | Various chromatin remodeling mutants are sensitive to
DMSO. Statistical significance between wild-type and mutant strains was
calculated by t-test, with ap < 0.001, bp < 0.01, and cp < 0.05. (A) Relative
growth assays for Set1C histone H3 methylase mutants in DMSO. (B)
Relative growth assays for DMSO-treated Set3C histone deacetylase
mutants. (C) Evaluation of DMSO treatment on strains lacking SAGA
histone H2B deubiquitylation module components. (D) Growth curves for
SAGA and Paf1 mutants in DMSO. (E) Relative growth experiments for
DMSO-exposed HIR mutants. For (A–C,E), relative growth ratios were
obtained and averaged for three independent cultures, while (D) displays
average area under the curve data for growth curves acquired from three
cultures.
complexes are required for DMSO tolerance in yeast, with var-
ious mutants displaying sensitivity at concentrations as low as
0.25% (Figures 1, 2). Although many DMSO resistance genes
are conserved in humans (Table 3), we were unable to con-
firm a role in DMSO tolerance for the COG5, NTG1, and YAF9
homologs in the nematode Caenorhabditis elegans or the COG7
and COG8 homologs in human fibroblasts (data not shown).
These results may indicate that DMSO’s mechanism of toxicity
in yeast is different from that exhibited in nematodes or human
cells. However, if the toxic mechanism remains similar, it is fea-
sible that compensatory cellular processes or genes are present in
these mutants.
During the preparation of this manuscript, a report was pub-
lished describing functional profiling of yeast mutants in DMSO
(Zhang et al., 2013), with findings congruent to those pre-
sented in this study (see Table 4 for a comparison of strains
identified). In this section, we discuss various aspects differen-
tiating our investigation from Zhang et al. (2013). First, while
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FIGURE 4 | DNA repair and other various mutants are sensitive to
DMSO. Relative growth assays were performed for three independent
cultures. Ratio means and standard errors are shown, with statistical
significance between wild-type and mutant strains calculated by t-test,
where ap < 0.001, bp < 0.01, and cp < 0.05. (A) Analysis of DNA repair
mutant growth in DMSO. (B) Relative growth assays in DMSO with
mutants lacking prefoldin components. (C) A summary of various additional
mutants tested for sensitivity to DMSO.
these researchers assessed growth of individual yeast mutants via
colony size on solid media, we performed functional profiling
in pooled liquid cultures under competitive growth conditions.
Our analyses, in which DNA sequences unique to each strain
are hybridized to a microarray after toxicant exposure, are able
to discern small growth defects and can identify sensitive strains
overlooked by other methods (Table 4). However, the stringency
of our DSSA may hinder identification of slow growing strains
or those close to background levels. Nevertheless, these data are
extremely relevant to those conducting pooled growth assays,
especially considering the increased popularity of automated
screens and high-throughput multiplexed barcode sequencing
to examine strain growth in DMSO-soluble toxicants or drugs
FIGURE 5 | Overexpression of Htz1p or Arp6p rescues DMSO
sensitivity in various mutants. Growth curves for three independent
cultures were obtained in the indicated doses of DMSO. The area under the
curve (AUC) means and standard error are shown. Statistical significance
between AUCs for corresponding doses in the empty vector and
overexpression strains was calculated by t-test, and is indicated by
ap < 0.001, bp < 0.01, and cp < 0.05.
(Smith et al., 2010, 2012). Second, compared to the use of 4 and
8% DMSO in Zhang et al. (2013), the concentrations utilized
in our screen (1%) and confirmation assays (0.25–2%) do not
inhibit growth of the BY4743 wild-type strain and represent
levels standard to functional screens (1% or less). The con-
trasting choice of doses may also account for differences in the
DMSO-sensitive strains identified by each screen. Third, we pro-
vide extensive DMSO dose-response analyses for novel DMSO-
sensitive strains as well as those concomitantly identified by
Zhang et al. (2013). Finally, our overexpression data demonstrates
that increased levels of Htz1p or Arp6p can rescue the growth of
various deletion strains in DMSO (Figure 5).
We have identified three cellular processes influencing DMSO
resistance in budding yeast: Golgi/ER trafficking, SWR1 com-
plex action, and DNA repair. Microarray analyses assessing the
response of S. cerevisiae to DMSO (Zhang et al., 2003) did not
identify any genes described in this study, however, correlation
between transcriptional events and genes required for growth
under a selective condition is often low (Giaever et al., 2002).
The requirement of COG and SNARE Golgi/ER genes for DMSO
tolerance (Figure 1) may reflect findings in human and rat hepa-
tocytes, where DMSO altered expression of genes associated with
SNARE interactions in vesicular transport (Sumida et al., 2011).
Furthermore, as a “chemical chaperone,” DMSO can mimic the
function of molecular chaperones (Papp and Csermely, 2006),
a group of proteins closely tied to Golgi/ER operations. The
DMSO sensitivity of histone H2A.Z and chromatin remodel-
ing mutants (Figures 2, 3) indicate DMSO may affect chromatin
structure. Lapeyre and Bekhor (1974) reported that 1% DMSO
decreased chromatin thermostability, while higher concentrations
promoted chromatin relaxation. Consistent with these findings,
Pommier et al. (1983) suggested DMSO increased domain (loop)
size by reducing DNA-protein attachment points after finding it
enhanced intercalator-induced DNA breakage. DMSO could con-
ceivably cause DNA damage, as demonstrated by DNA repair
mutant sensitivity (Figure 4A). DMSO damaged DNA in bull
sperm (Tas¸demir et al., 2013) and erythroleukemic cells (Scher
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Table 3 | Human orthologs of yeast genes required for DMSO
tolerance.
Yeast gene Human
ortholog(s)
Human protein description
ARP6 ACTR6 ARP6 actin-related protein 6 homolog
BDF1 EP300 Histone acetyltransferase
CDC73 CDC73 Component of the PAF1 complex; tumor
suppressor
COG5 COG5 Component of oligomeric Golgi complex 5
COG6 COG6 Component of oligomeric Golgi complex 6
COG7 COG7 Component of oligomeric Golgi complex 7
COG8 COG8 component of oligomeric Golgi complex 8
EAF3 MORF4L1 Component of the NuA4 histone
acetyltransferase complex
EAF6 MEAF6 Component of the NuA4 histone
acetyltransferase complex
EAF7 MRGBP Component of the NuA4 histone
acetyltransferase complex
GCN5 KAT2A Histone acetyltransferase
GOS1 GOSR1 Involved in ER-Golgi transport as well as
intra-Golgi transport
HIR1/2 HIRA Histone chaperone
HOS2 HDAC3 Histone deacetylase
HTZ1 H2AFZ Variant histone H2A; replaces conventional
H2A in a subset of nucleosomes
KAP123 IPO4 Nuclear transport receptor
MRE11 MRE11A Component of MRN complex; involved in
DNA double-strand break repair
NTG1 NTHL1 Apurinic and/or apyrimidinic endonuclease
and DNA N-glycosylase
PAC10 VBP1 Transfers target proteins to cytosolic
chaperonin
RRP8 RRP8 Component of the eNoSC complex;
mediates silencing of rDNA
SIF2 TBL1X Subunit in corepressor SMRT complex
along with HDAC3
SPP1 CXXC1 Recognizes CpG sequences and regulates
gene expression
SWC2 VPS72 subunit of acetyltransferase TRRAP/TIP60
and chromatin-remodeling SRCAP
SWC5 CFDP1 Craniofacial development protein 1; may
play role in embryogenesis
SWC6 ZNHIT1 Zinc finger, HIT-type containing 1
SWD1 RBBP5 Component of MLL1/MLL histone
methyltransferase complex
SWD3 WDR5 Component of MLL1/MLL histone
methyltransferase complex
SWR1 SRCAP Catalytic component of the
chromatin-remodeling SRCAP complex
UBP8 USP22 Histone deubiquitinating component of
SAGA histone acetylation complex
VAM7 SNAP25 t-SNARE involved in the molecular
regulation of neurotransmitter release
VPS51 VPS51 Required for both Golgi structure and
vesicular trafficking
VPS54 VPS54 Required for retrograde transport of
proteins from prevacuoles to the late Golgi
YAF9 YEATS4 Component of the NuA4 histone
acetyltransferase complex
YKE2 PFDN6 Subunit of heteromeric prefoldin; transfers
proteins to cytosolic chaperonin
Deletion of the yeast genes listed resulted in sensitivity to DMSO (shown in
alphabetical order).
Table 4 | A comparison between studies identifying yeast genes
responsible for DMSO tolerance.
DMSO tolerance genes DMSO tolerance genes
identified by Zhang et al. (2013) identified by this
and this study study
ARP6 ROM2 COG5 KAP123 UBC8
BDF1 SET3 COG8 MRE11 VPS54
CDC73 SWC2 (VPS72) EAF6 NTG1 YAF9
COG6 SWC3 EAF7 PAC10 YKE2
COG7 SWC6 (VPS71) EDO1 RIC1
EAF1 SWC7 GCN5 RRP8
EAF3 SWD1 GET1 SGF11
GOS1 SWR1 GET2 SIF2
HIR2 VAM7 HIR1 SPP1
HOS2 VPS51 HIR3 SWC5
HTZ1 HPC2 SWD3
DMSO tolerance genes identified by Zhang et al. (2013) were compared to those
identified in this study.
and Friend, 1978), and additionally altered expression of DNA
repair genes in human and rat hepatocytes (Sumida et al., 2011).
The experimental evidence integrating the seemingly discrete
processes of Golgi/ER transport, SWR1 complex action, andDNA
repair is limited. Strains lacking SWR1 and NuA4 components
exhibit synthetic lethality or sickness with various Golgi/ER trans-
port and DNA repair genes (Collins et al., 2007; Mitchell et al.,
2008; Costanzo et al., 2010; Hoppins et al., 2011), but mech-
anistic data explaining these findings are lacking. If Golgi/ER
transport is the crucial determinant of DMSO tolerance, it is rea-
sonable that loss of SWR1, which may repress transcription by
preventing histone H2A.Z deposition into chromatin (Meneghini
et al., 2003; Zhang et al., 2005), could confer DMSO sensitivity by
decreasing production of Golgi/ER transport genes. Expression
of COG7, a COG member involved in Golgi/ER trafficking, is
downregulated in htz1 and the SWR1 mutants swr1, swc2,
and swc5 (Morillo-Huesca et al., 2010), but others report the
nonessential COG genes are neither induced nor repressed in
the swr1 background (Meneghini et al., 2003). Alternatively,
if SWR1 or H2A.Z activity is the deciding factor in DMSO
resistance, defective Golgi/ER transport could prevent appropri-
ate processing and localization of SWR1 components or H2A.Z.
However, the expression of Golgi/ER, chromatin remodeling, or
DNA repair genes described herein are not altered in htz1,
and further, HTZ1 expression is unchanged in SWR1 or NuA4
mutants (Meneghini et al., 2003; Lindstrom et al., 2006; Lenstra
et al., 2011). The relationship of SWR1 to DNA repair is evi-
denced by its ability to cause genetic instability in the absence of
H2A.Z (Morillo-Huesca et al., 2010) and also deposit H2A.Z at
double-stranded DNA breaks (Kalocsay et al., 2009).
We provide valuable insight into the genetic requirements for
DMSO tolerance by identifying three major cellular processes—
Golgi/ER transport, SWR1 complex function, and DNA repair—
as important in DMSO resistance in S. cerevisiae. To separate
effects of DMSO from a compound of interest, it is crucial for
future yeast profiling studies to recognize that various deletion
strains may fall out of pooled cultures during treatment with
www.frontiersin.org August 2013 | Volume 4 | Article 154 | 7
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DMSO-solubilized drugs or toxicants. Data gathered by our study
can direct additional experimentation to decipher the cellular and
molecular mechanisms of DMSO action.
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